Gusacitinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gusacitinib, covering 2025-03-13 to 2025-03-13. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus [Phase 1]